Featured news
World-first Moorfields project shows great promise for treatment of chronic hypotony
A Moorfields study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony. This condition is characterised by abnormally low eye pressure, which alters the eye’s normal shape and internal structure. Over time, this can lead to progressive and permanent vision loss, often taking several years to result in blindness. Hypotony may develop as a result of underlying eye conditions that damage the part of the eye responsible for producing the fluid that maintains normal eye pressure.
